These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25877139)

  • 1. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
    Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
    Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
    Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.
    Chen Y; Zhang P; Wang J; Gong Q; An Y; Qian X; Zhang B; Li H; Gregg EW; Bennett PH; Li G
    Diabetologia; 2021 Jun; 64(6):1279-1287. PubMed ID: 33608769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
    Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH
    Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome study.
    Yu L; Wang J; Gong Q; An Y; Chen F; Chen Y; Chen X; He S; Qian X; Chen B; Dong F; Li H; Zhao F; Zhang B; Li G;
    Diabetes Obes Metab; 2024 Apr; 26(4):1188-1196. PubMed ID: 38168886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
    Pan XR; Li GW; Hu YH; Wang JX; Yang WY; An ZX; Hu ZX; Lin J; Xiao JZ; Cao HB; Liu PA; Jiang XG; Jiang YY; Wang JP; Zheng H; Zhang H; Bennett PH; Howard BV
    Diabetes Care; 1997 Apr; 20(4):537-44. PubMed ID: 9096977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
    Yoon U; Kwok LL; Magkidis A
    Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subjects with impaired glucose tolerance returned to normal glucose status for six years had lower long-term risk of diabetes: 20 years follow up of Daqing diabetes prevention study].
    Shen XX; Wang JP; Chen YY; An YL; Gong QH; Zhang B; Hong J; Shuai Y; Zhao F; Li H; Li GW
    Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):372-376. PubMed ID: 31060146
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.
    Peng M; He S; Wang J; An Y; Qian X; Zhang B; Zhang L; Chen B; Yang Z; Li G; Gong Q;
    Diabetes Obes Metab; 2024 Jun; 26(6):2329-2338. PubMed ID: 38488254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.
    Qian X; Wang J; Gong Q; An Y; Feng X; He S; Chen X; Wang W; Zhang L; Hui Y; Zhai X; Zhang B; Chen Y; Li G
    PLoS Med; 2024 Jul; 21(7):e1004419. PubMed ID: 38980837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.
    Goldberg RB; Temprosa M; Haffner S; Orchard TJ; Ratner RE; Fowler SE; Mather K; Marcovina S; Saudek C; Matulik MJ; Price D;
    Diabetes Care; 2009 Apr; 32(4):726-32. PubMed ID: 19171717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study.
    Hui Y; Wang J; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
    Endocrine; 2019 Jul; 65(1):46-52. PubMed ID: 31001730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.
    Eriksson KF; Lindgärde F
    Diabetologia; 1998 Sep; 41(9):1010-6. PubMed ID: 9754818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Zhang P; Wang J; Gregg EW; Cheng YJ; Li G; Bennett PH;
    Diabetes Obes Metab; 2021 Oct; 23(10):2385-2394. PubMed ID: 34212465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.
    Shen X; Zhang P; Wang J; An Y; Gregg EW; Zhang B; Li H; Gong Q; Chen Y; Shuai Y; Engelgau MM; Hu Y; Bennett PH; Li G
    Int J Stroke; 2018 Dec; 13(9):941-948. PubMed ID: 29956594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
    Kosaka K; Noda M; Kuzuya T
    Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired glucose tolerance predicts all-cause mortality among older men at high risk for cardiovascular disease in China.
    Fang F; Wang N; Yan S; Wang L; Lu Y; Li J; Li H; Pham G; Li C; Leng SX; Tian H
    Prim Care Diabetes; 2019 Dec; 13(6):495-504. PubMed ID: 30862424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.